全文获取类型
收费全文 | 63269篇 |
免费 | 4992篇 |
国内免费 | 182篇 |
专业分类
耳鼻咽喉 | 850篇 |
儿科学 | 1697篇 |
妇产科学 | 1275篇 |
基础医学 | 7982篇 |
口腔科学 | 1118篇 |
临床医学 | 7028篇 |
内科学 | 11804篇 |
皮肤病学 | 820篇 |
神经病学 | 5917篇 |
特种医学 | 2662篇 |
外国民族医学 | 2篇 |
外科学 | 10166篇 |
综合类 | 1086篇 |
现状与发展 | 1篇 |
一般理论 | 53篇 |
预防医学 | 5580篇 |
眼科学 | 1324篇 |
药学 | 4854篇 |
1篇 | |
中国医学 | 94篇 |
肿瘤学 | 4129篇 |
出版年
2023年 | 390篇 |
2022年 | 559篇 |
2021年 | 1441篇 |
2020年 | 824篇 |
2019年 | 1409篇 |
2018年 | 1685篇 |
2017年 | 1248篇 |
2016年 | 1261篇 |
2015年 | 1536篇 |
2014年 | 2222篇 |
2013年 | 2880篇 |
2012年 | 4352篇 |
2011年 | 4615篇 |
2010年 | 2568篇 |
2009年 | 2152篇 |
2008年 | 3798篇 |
2007年 | 4132篇 |
2006年 | 3914篇 |
2005年 | 3738篇 |
2004年 | 3291篇 |
2003年 | 3310篇 |
2002年 | 2961篇 |
2001年 | 886篇 |
2000年 | 764篇 |
1999年 | 836篇 |
1998年 | 688篇 |
1997年 | 513篇 |
1996年 | 445篇 |
1995年 | 440篇 |
1994年 | 377篇 |
1993年 | 331篇 |
1992年 | 545篇 |
1991年 | 546篇 |
1990年 | 545篇 |
1989年 | 508篇 |
1988年 | 521篇 |
1987年 | 518篇 |
1986年 | 423篇 |
1985年 | 473篇 |
1984年 | 410篇 |
1983年 | 350篇 |
1982年 | 303篇 |
1981年 | 254篇 |
1980年 | 267篇 |
1979年 | 327篇 |
1978年 | 281篇 |
1977年 | 201篇 |
1976年 | 218篇 |
1974年 | 217篇 |
1973年 | 207篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
991.
992.
993.
994.
995.
Michael J. Klingler Stephen K. Babitz Alexander Kutikov Riccardo Campi Georgios Hatzichristodoulou Francesco Sanguedolce Sabine Brookman-May Bulent Akdogan Umberto Capitanio Marco Roscigno Alessandro Volpe Martin Marszalek Robert G. Uzzo Alessandro Antonelli Johan Langenhuijsen Marco Carini Andrea Minervini Brian R. Lane 《Urologic oncology》2019,37(1):33-39
Purpose
Partial nephrectomy (PN) is standard for small renal masses, improving renal function by preserving renal parenchyma compared with radical nephrectomy. Recent work demonstrated that postoperative surgeon assessment of volume preservation (SAVP) and 3D imaging measurements agree and correlate with postoperative function. We hypothesize preoperative assessment of volume preservation (PAVP) with PN based on preoperative imaging will reliably indicate postoperative renal function.Materials and Methods
Data were collected from 336 patients undergoing PN for suspected renal cancer by 40 surgeons at 12 centers in Europe and the United States within the Surface-Intermediate-Base International Consortium. Surgeons recorded PAVP and SAVP for individual patients; pre- and postoperative glomerular filtration rate (GFR) was estimated by Chronic Kidney Disease Epidemiology Collaboration equations. Correlations between PAVP, SAVP, and postoperative GFR were assessed with linear regression models. Bland–Altman analysis was used to assess agreement between PAVP and SAVP with a significant cutoff of 5%.Results
Median PAVP was 90% (interquartile range [IQR] 85%–100%) and SAVP was 90% (IQR: 80%–94%). PAVP and SAVP were moderately correlated (R2?=?0.67, P < 0.0001) and deemed “interchangeable” by Bland–Altman analysis at a 5% acceptable rate of difference (95% CI: ?5.4, ?3.1). Median postoperative GFR was 77.3 (IQR: 56.2, 92.0). Both PAVP (R2?=?0.82, P < 0.0001) and SAVP (R2?=?0.83, P < 0.0001) were correlated with postoperative GFR. Multivariable models utilizing volume-adjusted GFR based on PAVP or SAVP significantly and similarly predicted postoperative GFR (R2?=?0.72 for each).Conclusion
Renal function is closely linked to the amount of parenchymal volume preservation, whether estimated prior to surgery (PAVP) or afterward (SAVP). PAVP provides reasonably accurate information for decision-making in patients considering PN. 相似文献996.
997.
Alzheimer’s disease (AD) is a neurodegenerative condition that occurs in two forms, an early-onset form that is genetically determined and a far more common late-onset form that is not. In both cases, the disease results in severe cognitive dysfunction, among other problems, and the late-onset form of the disease is now considered to be the most common cause of dementia among the elderly. While a good deal of research has been focused on elucidating the etiology of the late-onset form for more than two decades, results to date have been modest and have not yet engendered useful therapeutic strategies for cure of the disease. In this review, we discuss the prevalent ideas that have governed this research for several years, and we challenge these ideas with alternative findings suggesting a multifactorial etiology. We review promising newer ideas that may prove effective as therapeutic interventions for late-onset AD, as well as providing reliable means of earlier and more specific diagnosis of the disease process. In the discussions included here, we reference relevant clinical and basic science literature underlying research into disease etiology and pathogenesis, and we highlight current reviews on the various topics addressed. 相似文献
998.
999.
Rong Liu Brian Hoffpauir Shannon D Chilewski Janice Gamberdella Uma Kavita Jia Duo Carol Gleason Yan Zhang Renuka Pillutla Binodh DeSilva Lora Hamuro 《The AAPS journal》2017,19(1):82-91
The Gyrolab? xP is a microfluidic platform for conducting ligand binding assays (LBAs) and is recognized for its utility in discovery bioanalysis. However, few reports have focused on the technology for regulated bioanalysis. This technology has the advantage of low reagent consumption, low sample volume, and automated ligand binding methods. To improve bioanalysis testing timelines and increase the speed at which biotherapeutics are delivered to patients, we evaluated the technology for its potential to deliver high-quality data at reduced testing timelines for regulated bioanalysis. Six LBA methods were validated to support bioanalysis for GLP toxicokinetic or clinical pharmacokinetic studies. Validation, sample analysis, and method transfer are described. In total, approximately 4000 samples have been tested for regulated bioanalysis to support 6 GLP toxicology studies and approximately 1000 samples to support 2 clinical studies. Gyrolab? xP had high run pass rates (≥83%) and high incurred sample reanalysis (ISR) pass rates (>94%). The maximum total error observed across all QC levels for a given assay was <30% for all six LBAs. High instrument response precision (CV ≤5%) was observed across compact discs (CDs), and methods were validated to use a single standard curve across multiple CDs within a Gyrolab? xP run. Reduced bioanalysis timelines were achieved compared to standard manual plate-based methods, and methods were successfully transferred across testing labs, paving the way for this platform for use in late-stage clinical development. 相似文献
1000.